We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
-3.02%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.41B
AUM Growth
-$175M
Cap. Flow
-$69.4M
Cap. Flow %
-4.94%
Top 10 Hldgs %
19.17%
Holding
227
New
39
Increased
75
Reduced
46
Closed
36

Sector Composition

Rank Sector Weight
1 Healthcare 36.56%
2 Technology 16.86%
3 Financials 8.72%
4 Energy 7.73%
5 Industrials 6.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLAR icon
26
Clarus
CLAR
$143M
$15.5M 1.1%
678,723
+148,816
+28% +$3.45M
KRNT icon
27
Kornit Digital
KRNT
$791M
$15.3M 1.09%
185,022
-18,915
-9% -$1.82M
KRYS icon
28
Krystal Biotech
KRYS
$9.66B
$15.2M 1.08%
228,732
+37,421
+20% +$2.34M
BROS icon
29
Dutch Bros
BROS
$9.26B
$15M 1.07%
+271,527
New +$13.9M
INSP icon
30
Inspire Medical Systems
INSP
$1.74B
$14.6M 1.04%
+56,781
New +$13M
IIPR icon
31
Innovative Industrial Properties
IIPR
$1.72B
$14.3M 1.02%
69,596
+834
+1% +$164K
ALNY icon
32
Alnylam Pharmaceuticals
ALNY
$29.3B
$14.1M 1%
+86,164
New +$13.1M
TWST icon
33
Twist Bioscience
TWST
$7.25B
$13.8M 0.98%
279,864
+114,813
+70% +$6.36M
NVDA icon
34
NVIDIA
NVDA
$5.42T
$13.7M 0.97%
501,180
-134,160
-21% -$3.36M
PIII icon
35
P3 Health Partners
PIII
$38.5M
$13.3M 0.94%
33,918
+12,843
+61% +$3.85M
ALBO
36
DELISTED
Albireo Pharma Inc
ALBO
$13.1M 0.93%
+439,235
New +$12.9M
SLGC
37
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$12.7M 0.9%
1,580,871
+600,065
+61% +$5.29M
DBRG icon
38
DigitalBridge
DBRG
$2.95B
$12.6M 0.89%
436,535
+221,076
+103% +$6.44M
SDGR icon
39
Schrodinger
SDGR
$1.36B
$12.5M 0.89%
365,016
+243,940
+201% +$7.41M
VEEV icon
40
Veeva Systems
VEEV
$37.4B
$11.5M 0.82%
54,255
+22,459
+71% +$4.87M
BAC icon
41
Bank of America
BAC
$442B
$11.4M 0.81%
277,500
-26,500
-9% -$1.2M
GH icon
42
Guardant Health
GH
$22.6B
$11.3M 0.8%
170,198
+57,985
+52% +$3.97M
BX icon
43
Blackstone
BX
$110B
$10.6M 0.75%
83,461
-46,171
-36% -$5.63M
AMRC icon
44
Ameresco
AMRC
$1.36B
$10.6M 0.75%
132,972
+12,603
+10% +$795K
MASS icon
45
908 Devices
MASS
$364M
$10.5M 0.75%
552,801
+242,968
+78% +$4.18M
VRRM icon
46
Verra Mobility
VRRM
$744M
$10.3M 0.73%
632,641
+158,012
+33% +$2.54M
KKR.PRC
47
DELISTED
KKR & Co. Inc. 6.00% Series C Mandatory Convertible Preferred Stock
KKR.PRC
0
TKNO icon
48
Alpha Teknova
TKNO
$347M
$9.95M 0.71%
720,524
+76,139
+12% +$1.2M
RRX icon
49
Regal Rexnord
RRX
$11.9B
$9.92M 0.71%
66,701
+12,459
+23% +$2M
FANG icon
50
Diamondback Energy
FANG
$52.7B
$9.51M 0.68%
69,388
+30,293
+77% +$3.94M

Similar funds

Nicholas Investment Partners's Q1 2022 Portfolio in Review

As of Q1 2022, Nicholas Investment Partners held 227 positions worth $1.41B, down 11% from $1.58B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Nicholas Investment Partners withdrew a net $69.4M in Q1 2022, closing 36 positions and reducing 46 holdings. Its most notable exit was Western Alliance Bancorporation, an estimated $24.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 30% a quarter earlier, followed by Technology and Financials.

Against the trend, Nicholas Investment Partners opened a new position in HealthEquity worth $21.2M.

  • Nicholas Investment Partners's largest Q1 2022 buy was HealthEquity: 314,704 shares worth $21.2M.
  • Nicholas Investment Partners added most to Inari Medical, Inc. Common Stock in Q1 2022, an estimated $9.51M increase.
  • Nicholas Investment Partners's biggest Q1 2022 reduction was Chart Industries, cutting an estimated $14.2M.
  • Nicholas Investment Partners fully exited Western Alliance Bancorporation in Q1 2022, selling an estimated $24.1M.
  • Nicholas Investment Partners's ten largest holdings make up 19% of its $1.41B portfolio in Q1 2022.
  • Nicholas Investment Partners opened 39 new positions and closed 36 in Q1 2022.
  • Nicholas Investment Partners's portfolio value fell 11% quarter-over-quarter to $1.41B.

Based on Nicholas Investment Partners's 13F filing for Q1 2022, filed 10 May 2022.